Clinical Pharmacokinetic & Dosing Calculators
Clinical pharmacists ensure the safety and efficacy of high-risk pharmacotherapies. Achieving optimal drug levels requires accounting for patient-specific renal clearance rates, hepatic function, body composition index variables, and drug-drug interactions. Sourced from therapeutic drug monitoring (TDM) guidelines, these calculators support pharmacists and clinicians in optimizing patient-specific dosing regimens.
Primary Clinical Pharmacy Tools
Our pharmacists' portal covers advanced dosing and monitoring parameters:
- Renal Dosage Optimization: Guides dose reductions and interval extensions for anticoagulants, antibiotics, and chemotherapeutic agents based on CrCl.
- Obesity CrCl Calculations: Applies Adjusted Body Weight (AdjBW) and Ideal Body Weight in Cockcroft-Gault assessments to prevent dosing errors in patients with BMI ≥ 30.
- Narrow-Therapeutic antibiotics: Features Vancomycin AUC/MIC target calculations and Extended-Interval Aminoglycoside dosing models.
- Phenytoin Corrections: Corrects raw serum phenytoin levels for hypoalbuminemia and end-stage renal disease using the Sheiner-Tozer equation.
- Hepatic Adjustments: Guides medication reviews using Child-Pugh clinical classifications.
BEDSIDE FAQs
Phenytoin is highly protein-bound (approximately 90%). In patients with low albumin (< 4 g/dL), there are fewer binding sites, which increases the active, free fraction of phenytoin. Because standard laboratory assays measure total (bound + free) phenytoin, they can underestimate the active, pharmacologically active fraction. The Sheiner-Tozer equation estimates the corrected total level as:
Consensus guidelines recommend targeting a 24-hour **AUC/MIC ratio of 400 to 600** (assuming a baseline MIC of 1 mg/L) for serious MRSA infections. This range maximizes bactericidal efficacy while minimizing the incidence of vancomycin-induced nephrotoxicity.